Back
Atara Biotherapeutics Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Buy
61
ATRA
Atara Biotherapeutics
Last Price:
$8.47
Seasonality Move:
-12.01%
7 Day Trial
ALL ACCESS PASS
$
7
The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing slight selling pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.84 | Buy |
| 20-day SMA: | 7.33 | Buy |
| 50-day SMA: | 6.86 | Buy |
| 200-day SMA: | 8.76 | Sell |
| 8-day EMA: | 7.9 | Buy |
| 20-day EMA: | 7.51 | Buy |
| 50-day EMA: | 7.31 | Buy |
| 200-day EMA: | 9.87 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 63.93 | Buy |
| Chaikin Money Flow: | -17055 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.88 - 7.92) | Buy |
| Bollinger Bands (100): | (5.8 - 9.24) | Buy |
Atara Biotherapeutics Technical Analysis
| May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 8.33 while ATRA 8-day simple moving average is 7.84, which is a Buy signal.
-
The stock price of ATRA is 8.33 while Atara Biotherapeutics 20-day SMA is 7.33, which makes it a Buy.
-
Atara Biotherapeutics 50-day simple moving average is 6.86 while ATRA share price is 8.33, making it a Buy technically.
-
ATRA stock price is 8.33 and Atara Biotherapeutics 200-day simple moving average is 8.76, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Buy
61
Atara Biotherapeutics (ATRA)
is a Buy
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a BuyThe current Atara Biotherapeutics [ATRA] share price is $8.33. The Score for ATRA is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
49.7M
Price in USD:
8.33
Share Volume:
61.9K
Atara Biotherapeutics 52-Week Range
52-Week High:
18.71
52-Week Low:
5.01
Buy
61
Atara Biotherapeutics (ATRA)
is a Buy
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?The Atara Biotherapeutics stock price is 8.33 USD today.
-
Will ATRA stock go up or go down?Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atara Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is not overvalued.
Is Atara Biotherapeutics Stock a Buy?
-
Atara Biotherapeutics share price is 8.33 while ATRA 8-day exponential moving average is 7.90, which is a Buy signal.
-
The stock price of ATRA is 8.33 while Atara Biotherapeutics 20-day EMA is 7.51, which makes it a Buy.
-
Atara Biotherapeutics 50-day exponential moving average is 7.31 while ATRA share price is 8.33, making it a Buy technically.
-
ATRA stock price is 8.33 and Atara Biotherapeutics 200-day simple moving average is 9.87, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.51 per share, and a decrease next year of $2.47 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
-
ATRA Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Atara Biotherapeutics is a Buy
-
Atara Biotherapeutics Relative Strength Index (RSI) is 63.93, which suggest Atara Biotherapeutics is overbought
-
The Bollinger Bands (25) for Atara Biotherapeutics is (6.88 - 7.92), which suggest Atara Biotherapeutics is a Buy
-
The Bollinger Bands (100) for Atara Biotherapeutics is (5.8 - 9.24), which suggest Atara Biotherapeutics is a Buy
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.